MEDTRONIC HEART VALVES DIVISION EVOLUT PRO PLUS VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number EVPROPLUS-29 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Non specific EKG/ECG Changes (1817)
|
Event Date 07/21/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Select patient information cannot be included in the regulatory report due to regional privacy regulations.Medtronic has requested additional information pertaining to this reportable event.If additional reportable information is received, a supplemental report will be submitted.Continuation of d10: product id {d-evprop2329}; product lot/serial number {unknown}; product type: {delivery catheter system (dcs)}; implant date {na}; explant date {na} product id {l-evprop2329}; product lot/serial number {unknown}; product type: {compression loading system (cls)}; implant date {na}; explant date {na}.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that following the implant of this transcatheter bioprosthetic valve, a temporary junctional escape rhythm occurred.Treatment included a change to the patient's guideline directed medical therapy by stopping metoprolol.The event resolved the following day.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Updated data: a - 3b.Gender.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|